Changeflow GovPing Government General Class 2 Device Recall: Medline Heart Transplant...
Urgent Enforcement Amended Final

Class 2 Device Recall: Medline Heart Transplant Biopsy Kit (39 Units)

Favicon for changeflow.com FDA Device Recalls (Class II)
Filed
Detected
Email

Summary

FDA Class II recall initiated for Medline Heart Transplant Biopsy Kit (Model DYNJ37543A, Lot 24DDA193) affecting 39 units distributed nationwide. The recall was triggered when 510(k) regulatory clearances for certain component syringes, guidewires, and high-pressure tubing were rescinded, leaving the kit without a valid marketing application. Medline is notifying consignees to quarantine affected product and is issuing over-labels to allow removal of the non-compliant components before kit use.

“The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded.”

FDA , verbatim from source
Published by FDA on accessdata.fda.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

Medline Industries initiated a Class II recall for 39 units of its Heart Transplant Biopsy Kit (Model DYNJ37543A, Lot 24DDA193) after 510(k) clearances for component syringes, guidewires, and high-pressure tubing were rescinded by FDA, eliminating the legal basis for marketing the device. The FDA-determined cause is 'No Marketing Application.'

Healthcare providers and distributors holding affected inventory must quarantine the product and contact Medline via the recall portal to receive over-labels that will permit continued use of the kit after removal of the non-compliant components. Distributors are required to pass the recall notification down the supply chain per FDA regulations.

What to do next

  1. Immediately check your stock for the affected item number(s) and lot number(s) listed in the recall portal. Quarantine all affected product.
  2. Complete your response form. List the quantity of affected product you have in inventory on the form. Even if you do not have any affected product, submit the form to Website link: https://recalls.medline.com
  3. If you are a distributor or have resold or transferred this product to another company or individual, you are required by FDA regulations to notify them of this recall communication.

Archived snapshot

Apr 21, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Class 2 Device Recall Medline Kits

- Databases

| |

| 510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards |

| CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC | |

| New Search | ) |

| | Class 2 Device Recall Medline Kits | |

Date Initiated by Firm February 25, 2026
Date Posted April 17, 2026
Recall Status Open , Classified
Recall Number Z-1838-2026
Recall Event ID 98599
Product Classification CT biopsy tray - Product Code OFG
Product Medline Kits:
1) HEART TRANSPLANT BIOPSY, Model Number: DYNJ37543A
Code Information 1) DYNJ37543A, UDI-DI: 10193489919561(each), 40193489919562(case), Lot Number: 24DDA193
FEI Number 1417592
Recalling Firm/
Manufacturer Medline Industries, LP

3 Lakes Dr
Northfield IL 60093-2753 |
| For Additional Information Contact | Haley Barclay
866-359-1704 |
| Manufacturer Reason
for Recall | The 510(k) regulatory clearances for certain Control Syringes, Guidewires, and/or High-Pressure Tubing have been rescinded. |
| FDA Determined
Cause | No Marketing Application |
| Action | An URGENT MEDICAL DEVICE RECALL dated 2/25/26 was sent to customers.

REQUIRED ACTION:
1. Immediately check your stock for the affected item number(s) and lot number(s) listed in the recall portal. Quarantine all affected product.
2. Complete your response form. List the quantity of affected product you have in inventory on the form. Even if you do not have any affected product, submit the form to
Website link: https://recalls.medline.com Recall Reference #: R-26-020-FGX1
Recall Code: 3. When we receive your response form, we will send over-labels via FedEx overnight to place on affected inventory, with instructions for your staff to remove and discard the affected component prior to using the kit.
4. If you are a distributor or have resold or transferred this product to another company or individual, you are required by FDA regulations to notify them of this recall communication. Include your customers quantities on your response form. When we receive your response form, we will send over-labels to provide to your customers.
Any questions? Contact the Recall Department at 866-359-1704 or recalls@medline.com.

*** An Urgent Medical Device Recall notification letter dated 3/2/26 was sent to customers.

This is a follow-up to a Medline notification you may have received on February 25, 2026. New item numbers and lot numbers have been included with this communication. Recipients receiving this notification for the first time were not affected by the original notification.

REQUIRED ACTIONS:
same as for 2/25/26 letter |
| Quantity in Commerce | 39 units |
| Distribution | US Nationwide distribution. |
| Total Product Life Cycle | TPLC Device Report |

| 1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.

3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes. | |

Get daily alerts for FDA Device Recalls (Class II)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
FDA
Filed
February 25th, 2026
Instrument
Enforcement
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Substantive

Who this affects

Applies to
Medical device makers Healthcare providers Distributors
Industry sector
3345 Medical Device Manufacturing
Activity scope
Device recall response Product quarantine
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Product Safety Healthcare

Get alerts for this source

We'll email you when FDA Device Recalls (Class II) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!